Pfizer-BioNTech Vaccine Deliveries to Start Before Christmas
Pfizer Inc and BioNTech are likely to secure emergency US and European authorization for their COVID-19 vaccine next month, the companies commented Wednesday, following final trial results showing a 95% success rate and no serious side effects.
The US Food and Drug Administration (FDA) could grant emergency-use by the middle of December, while conditional approval in the European Union could, in turn, be secured in the second half of December.
"If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively», BioNTech Chief Executive - Ugur Sahin commented.
Sahin further added that US emergency use authorization (EUA) would be applied for on Friday. An FDA advisory committee plans to meet from the 8-10th of December to discuss the vaccine, a competent source said.
*The products advertised are only available to clients under Fondex Limited Seychelles (SDL No: SD037).
Cookies on Fondex
These cookies fall under the following categories: essential, functional and marketing cookies. Marketing cookies may also include third-party cookies.
You can customize your selection of which cookies you want to accept.
These cookies are necessary for the website to function correctly and cannot be switched off.
Functional cookies allow the website to remember users' preferences and the choices you make on the website such as username, region, and language.
The Company would like to inform you that it will terminate its operations under the "Fondex" brand by 30th of December 2022. If you wish to open a trading account, kindly visit topfx.com.sc